Navidea Biopharmaceuticals, Inc. News Headlines

NAVB 
$1.79
*  
0.21
10.5%
Get NAVB Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading NAVB now
Exchange: AMEX
Industry: Health Care
Community Rating:
View:    NAVB Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Navidea Biopharmaceuticals: 4 Reasons To Buy This $2 Lottery Ticket
3/10/2014 11:55:00 AM - Seeking Alpha


Do Away With The Pill-A-Day Biotech Model: Steve Brozak
2/7/2014 2:05:00 PM - Seeking Alpha


Sector Update: Healthcare Shares Flat to Higher Pre-Market; Galena Biopharma up 5% on Enrolling Patients in Phase 2 Study
1/7/2014 8:41:18 AM - MT Newswires


Sector Update: Healthcare
1/7/2014 8:39:59 AM - MT Newswires


Navidea Biopharmaceuticals Inc. - A Follow Up?
12/24/2013 8:02:00 AM - Seeking Alpha


Navidea Biopharmaceuticals (NAVB) Jumps: Stock Rises 5.9% - Tale of the Tape
12/18/2013 8:32:58 AM - Zacks.com


Sector Update: Healthcare Shares Mixed Pre-Market; Navidea up 19% on Fast Track For Diagnostic Tool
12/10/2013 8:26:01 AM - MT Newswires


Sector Update: Healthcare
12/10/2013 8:21:35 AM - MT Newswires


Navidea Biopharmaceuticals (NAVB) Surges: Stock Moves 10.2% Higher - Tale of the Tape
12/5/2013 9:06:33 AM - Zacks.com


2013 Biotech Watchlist Update: Companies Climb And Crumble On Catalysts
11/1/2013 11:48:00 AM - Seeking Alpha


Navidea Is On Track To File SNDA For Lymphoseek; CEO Expects A Positive Outcome
10/30/2013 9:22:00 AM - Seeking Alpha


Irrational Sell-Off After Crede Sale Leaves Navidea Biopharmaceuticals Very Undervalued
10/21/2013 7:41:00 AM - Seeking Alpha


Navidea Biopharmaceuticals Inc. Enters Oversold Territory - Tale of the Tape
10/18/2013 5:05:01 AM - Zacks.com


Does Navidea's Recent Offering Make It A Buy Or Sell?
9/30/2013 9:46:00 AM - Seeking Alpha


2 More Bold Speculative Biotech Plays
9/29/2013 7:18:00 AM - Seeking Alpha


Navidea - Worth A Look?
9/4/2013 1:40:00 AM - Seeking Alpha


3 Companies With High Short Interest And Improving Outlooks
8/26/2013 1:23:00 PM - Seeking Alpha


Sector Update: Healthcare Shares Higher in Pre-Bell
8/22/2013 7:09:30 AM - MT Newswires


Sector Update: Healthcare
8/22/2013 7:05:45 AM - MT Newswires


Healthcare Stocks Follow Broader Markets Lower; Navidea Up Slightly After Lymphoseek Approved For Medicare
8/21/2013 1:02:50 PM - MT Newswires


Sector Update: Healthcare
8/21/2013 1:01:44 PM - MT Newswires


Navidea: Positive News And Short Interest Trend
8/19/2013 5:50:00 AM - Seeking Alpha


Sector Update: Healthcare Shares Mixed On Results; Cumberland Down 14%, WellCare Hits 52 Week Highs, Navidea Down 4%
8/7/2013 11:11:20 AM - MT Newswires


Sector Update: Healthcare
8/7/2013 11:04:18 AM - MT Newswires


Sector Update: Healthcare Shares Flat; Ariad's Q2 Net Loss Widens, But Better than Street Estimate
8/7/2013 7:29:32 AM - MT Newswires